Breaking News

Gilead Sciences Inc (GILD)

Symbol	Exchange	Currency
GILD	NASDAQ	USD	Real-time
0QYQ	London	USD	Real-time
GILD	Mexico	MXN	Delayed
GGILD	Milan	EUR	Real-time
GILD	Xetra	EUR	Delayed
GILD	Frankfurt	EUR	Delayed
GILD	TradeGate	EUR	Delayed
GILDm	Buenos Aires	ARS	Delayed
GILD34	B3	BRL	Delayed
GILD	Vienna	EUR	Real-time
GILD	Lima	USD	Delayed

Add to/Remove from Watchlist Add to Watchlist

107.72 -1.39 -1.27%

- Closed. Currency in USD

After Hours

107.64

-0.08

-0.08%

- Real-time Data

Type: Equity

Market: United States

Volume: 7,968,878
Bid/Ask: 0.00 / 0.00
Day's Range: 107.39 - 108.77

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

Gilead Sciences Inc Company Profile

Get an in-depth profile of Gilead Sciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

17600

Equity Type

ORD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Contact Information

Address 333 Lakeside Drive
Foster City, 94404
United States

Phone 650 574 3000

Fax 650 578 9264

Web www.gilead.com

Top Executives

Name	Age	Since	Title
Grace E. Colon	56	2023	Chairman of the Board
Paul E. Klotman	-	-	Member of the Scientific Advisory Board
Paul Berg	98	1998	Member of Scientific Advisory Board
Eric J. Topol	71	-	Member of Scientific Advisory Board
John W. Mellors	87	-	Member of the Scientific Advisory Board
Robert A. Harrington	64	-	Member of the Scientific Advisory Board
Eugene R. Schiff	-	-	Member of the Scientific Advisory Board
Joel R. Huff	-	-	Chairperson of Scientific Advisory Board
Malcolm MacCoss	77	-	Member of Scientific Advisory Board
Nezam H. Afdhal	68	-	Member of Scientific Advisory Board
Daniel P. O'Day	60	2019	Chairman & CEO
Harish M. Manwani	72	2018	Independent Director
Jeffrey A. Bluestone	72	2020	Independent Director
Kelly A. Kramer	57	2016	Independent Director
Sandra J. Horning	76	2020	Independent Director
Javier J. Rodriguez	54	2020	Independent Director
Anthony Welters	70	2020	Lead Independent Director
Robert T. Schooley	-	-	Member of the Scientific Advisory Board
Francis V. Chisari	-	-	Member of the Scientific Advisory Board
Brian J. Druker	69	-	Member of the Scientific Advisory Board
Kenneth C. Anderson	74	-	Member of the Scientific Advisory Board
Ted W. Love	66	2024	Independent Director
Jacqueline K. Barton	72	1989	Independent Director
Mark C. Genovese	-	-	Member of Scientific Advisory Board

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

OverBurn Mar 11, 2025 4:00PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Time for 95??

0 1

Report

Giuseppe Giannachi Jun 20, 2024 11:38AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

The news seems amazing. 100% AIDS prevention...?

10 0

Report

Maria Kenny Jun 11, 2024 9:31AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Acquisition decreased EPS. This has 40% upside by January 2025. Hold. Do not sell.

5 0

Report

Luis Anderson Jul 14, 2023 9:50AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

time to buy

11 0

Report

Bugman CV Apr 28, 2022 1:44PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Who cares about dividends when this stock shows weakness year after year, is not a good deal to get 5% per year if you are constantly worried about this stock sinks under 2013 lows

3 2

Report

Jorge Almeida Pereira Apr 28, 2022 1:44PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Are you a coinbase client?

1 0

Report

Luis Anderson Apr 28, 2022 1:44PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Jorge Almeida Pereira lol

0 0

Report

Keith Chan Mar 08, 2022 10:59AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

it sucks...

2 3

Report

Dale Le Feb 17, 2022 9:37PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

invest stock gild.us at basel markets to take home divedends

0 0

Report

Manny Drake Jan 28, 2022 3:06PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Projected earnings beat but I'd bet it doesn't move the needle -

0 0

Report

Tedeski Rukker Jan 07, 2022 6:56PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Another 15 or so shares into this.

0 1

Report

Ted Trukker Nov 19, 2021 2:15PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

I've held this since 2014 or so. COULD have picked NVDA for approx 15 - 20 😒Did I pick the winner eh?

7 2

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="232982506">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="232982506" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="232982506" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="232982506">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="238016321">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="238016321" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="238016321" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="238016321">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	41,902.5	+42.5	+0.10%
US 500	5,855.1	+10.6	+0.18%
Dow Jones	41,860.01	-817.23	-1.91%
S&P 500	5,844.55	-95.91	-1.61%
Nasdaq	18,872.64	-270.07	-1.41%
S&P 500 VIX	20.87	+2.78	+15.37%
Dollar Index	99.470	-0.002	0.00%

Crude Oil WTI	61.22	-0.35	-0.57%
Brent Oil	64.53	-0.11	-0.17%
Natural Gas	3.359	0.000	0.00%
Gold	3,332.40	+18.90	+0.57%
Silver	33.675	+0.029	+0.09%
Copper	4.6758	+0.0183	+0.39%
US Soybeans	1,053.50	-8.25	-0.78%

U.S. 10Y	4.601	+0.004	+0.09%
U.S. 30Y	5.096	+0.006	+0.12%
U.S. 5Y	4.157	0.000	0.00%
U.S. 3M	4.400	+0.057	+1.31%
US 10Y T-Note	109.48	-0.02	-0.01%
Euro Bund	129.61	-0.28	-0.22%
10-2 Yield Spread	31.32	+4.15	+15.27%

Apple	202.09	-4.77	-2.31%
NVIDIA	131.80	-2.58	-1.92%
Alphabet A	168.56	+4.58	+2.79%
Tesla	334.62	-9.20	-2.68%
Amazon.com	201.12	-2.95	-1.45%
Netflix	1,194.63	+2.61	+0.22%
Meta Platforms	635.50	-1.60	-0.25%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GILD	107.72	-1.39	-1.27%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	131.80	-1.92%	270.61M
TSLA	334.62	-2.68%	102.35M
PLTR	120.54	-4.02%	76.34M
GOOGL	168.56	+2.79%	73.42M
AAPL	202.09	-2.31%	59.21M
UNH	303.00	-5.78%	41.30M
MSFT	452.57	-1.22%	19.22M

Name	Last	Chg. %	Vol.
GOOG	170.05	+2.86%	44.92M
GOOGL	168.56	+2.79%	73.42M
CF	89.35	+1.63%	3.36M
CME	281.74	+1.39%	2.22M
CBOE	228.52	+1.09%	872.88K
MELI	2,601.97	+0.88%	344.62K
MSI	426.43	+0.83%	1.09M

Name	Last	Chg. %	Vol.
FICO	1,707.94	-15.74%	937.99K
AES	10.13	-9.92%	43.16M
MRNA	25.81	-7.79%	16.29M
PSX	111.78	-7.54%	7.04M
PANW	181.26	-6.80%	19.05M
EFX	258.50	-6.69%	2.18M
CRL	134.94	-5.98%	799.10K